logo
You can slow cognitive decline as you age, large study finds. Here's how

You can slow cognitive decline as you age, large study finds. Here's how

CTV News2 days ago
At 62, Phyllis Jones felt trapped in darkness. She was traumatized by her mother's recent death, ongoing pandemic stress and an increasingly toxic work environment. A sudden panic attack led to a medical leave.
Her depression worsened until the day her 33-year-old son sadly told her, 'Mom, I didn't think I would have to be your caregiver at this stage in your life.'
'For me, that was the wake-up call,' Jones, now 66, told CNN. 'That's when I found the POINTER study and my life changed. What I accomplished during the study was phenomenal — I'm a new person.'
The Protect Brain Health Through Lifestyle Intervention to Reduce Risk, or U.S. POINTER study, is the largest randomized clinical trial in the United States designed to examine whether lifestyle interventions can protect cognitive function in older adults.
'These are cognitively healthy people between the ages of 60 and 79 who, to be in the study, had to be completely sedentary and at risk for dementia due to health issues such as prediabetes and borderline high blood pressure,' said principal investigator Laura Baker, a professor of gerontology, geriatrics and internal medicine at Wake Forest University School of Medicine in Winston-Salem, North Carolina.
Approximately one-half of the 2,111 study participants attended 38 structured team meetings over two years in local neighborhoods near Chicago, Houston, Winston-Salem, Sacramento, California, and Providence, Rhode Island. During each session, a trained facilitator provided guidance on how to exercise and eat for the brain, and explained the importance of socialization, the use of brain-training games, and the basics of brain health. The team leader also held the group accountable for logging blood pressure and other vitals. Physical and cognitive exams by a physician occurred every six months.
At six team meetings, the other half of the study's participants learned about brain health and were encouraged to select lifestyle changes that best suited their schedules. This group was self-guided, with no goal-directed coaching. These participants also received physical and cognitive exams every six months.
The two-year results of the US$50 million study, funded by the Alzheimer's Association, were simultaneously presented Monday at the 2025 Alzheimer's Association International Conference in Toronto and published in the journal JAMA.
'We found people in the structured program appeared to delay normal cognitive aging by one to nearly two years over and above the self-guided group — people who did not receive the same degree of support,' Baker said. 'However, the self-guided group improved their cognitive scores over time as well.'
Exercise, diet and socializing are key
Exercise was the first challenge. Like the other groups across the country, Jones and her Aurora, Illinois, team received YMCA memberships and lessons on how to use the gym equipment. Jones was told to use aerobic exercise to raise her heart rate for 30 minutes a day while adding strength training and stretching several times a week.
At first, it wasn't easy.
The study participants wore fitness trackers that monitored their activity, Jones said. 'After that first 10 minutes, I was sweating and exhausted,' she said. 'But we went slow, adding 10 minutes at a time, and we kept each other honest. Now I just love to work out.'
Four weeks later, teams were given a new challenge — beginning the Mediterranean-DASH Intervention for Neurodegenerative Delay, or MIND diet. The diet combines the best of the Mediterranean diet with the salt restrictions of the DASH diet, which stands for Dietary Approaches to Stop Hypertension.
'They gave us a refrigerator chart with foods to limit and foods to enjoy,' Jones said. 'We had to eat berries and vegetables most days, including green leafy veggies, which was a separate item. We had to have 2 tablespoons of extra-virgin olive oil once every day.'
Foods to limit included fried food, processed meat, dairy, cheese and butter. Restrictions were also in place for sugary sweets. 'But we could have dessert four times a week,' Jones added. 'That's awesome because you're not completely depriving yourself.'
Another pillar of the program was requiring study participants to familiarize themselves with their vital signs, Wake Forest's Baker said. 'If at any point we asked them, 'What's your average blood pressure?' they should be able to tell us,' she said. 'We encouraged people to monitor their blood sugar as well.'
Later came brain training, via memberships to a popular, Web-based cognitive training app. While some scientists say the benefits of such online brain programs have yet to be proven, Jones said she enjoyed the mental stimulation.
Becoming better at socializing was another key part of the program. The researchers tasked teams with assignments, such as speaking to strangers or going out with friends.
'I found my best friend, Patty Kelly, on my team,' Jones said. 'At 81, she's older than me, but we do all sorts of things together — in fact, she's coming with me to Toronto when I speak at the Alzheimer's conference.
'Isolation is horrible for your brain,' she added. 'But once you get to a point where you are moving and eating healthy, your energy level changes, and I think you automatically become more social.'
As the study progressed, the researchers reduced check-ins to twice a month, then once a month, Baker said.
'We were trying to get people to say, 'I am now a healthy person,' because if you believe that, you start making decisions which agree with the new perception of yourself,' she said.
'So in the beginning, we were holding their hands, but by the end, they were flying on their own,' Baker added. 'And that was the whole idea — get them to fly on their own.'
'Brain health is a long game'
Because researchers tracked each team closely, the study has a wealth of data that has yet to be mined.
'On any given day, I could go into our web-based data system and see how much exercise someone's doing, whether they've logged into brain training that day, what's their latest MIND diet score, and whether they'd attended the last team meeting,' Baker said.
'We also have sleep data, blood biomarkers, brain scans and other variables, which will provide more clarity on which parts of the intervention were most successful.'
Digging deeper into the data is important, Baker says, because the study has limitations, such as the potential for a well-known phenomenon called the practice effect.
'Even though we use different stimuli within tests, the act of taking a test over and over makes you more familiar with the situation — you know where the clinic is, where to park, you're more comfortable with your examiner,' she said.
'You're not really smarter, you're just more relaxed and comfortable, so therefore you do better on the test,' Baker said. 'So while we're thrilled both groups in US POINTER appear to have improved their global cognition (thinking, learning and problem-solving), we have to be cautious in our interpretations.'
It's important to note the POINTER study was not designed to provide the more immersive lifestyle interventions needed for people with early stages of Alzheimer's, said Dr. Dean Ornish, a professor of medicine at the University of California, San Francisco.
Ornish published a June 2024 clinical trial that found a strict vegan diet, daily exercise, structured stress reduction and frequent socialization could often stop the decline or even improve cognition in those already experiencing from early-stage Alzheimer's disease, not just for those at risk for it.
'The US POINTER randomized clinical trial is a landmark study showing that moderate lifestyle changes in diet, exercise, socialization and more can improve cognition in those at risk for dementia,' said Ornish, creator of the Ornish diet and lifestyle medicine program and coauthor of 'Undo It!: How Simple Lifestyle Changes Can Reverse Most Chronic Diseases.'
'It complements our randomized clinical trial findings which found that more intensive multiple lifestyle changes often improve cognition in those already diagnosed with early-stage Alzheimer's disease,' Ornish said. 'But the US POINTER study showed that more moderate lifestyle changes may be sufficient to help prevent it.'
In reality, two years isn't sufficient to track brain changes over time, said study coauthor Maria Carillo, chief science officer of the Alzheimer's Association.
'We really want to make recommendations that are evidence based,' Carillo told CNN. 'That's why we have invested another $40 million in a four-year follow-up, and I believe over 80% of the original participants have joined.
'Brain health is a long game,' she added. 'It's hard to track, but over time, change can be meaningful.'
By Sandee LaMotte, CNN
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Want Another $500 in Annual Dividend Income? Invest $6,900 in These 3 High-Yield Stocks.
Want Another $500 in Annual Dividend Income? Invest $6,900 in These 3 High-Yield Stocks.

Globe and Mail

time5 hours ago

  • Globe and Mail

Want Another $500 in Annual Dividend Income? Invest $6,900 in These 3 High-Yield Stocks.

Key Points Altria Group's cigarette sales are in decline, but smokeless options are picking up the slack. Healthpeak Properties is a leading healthcare-related real estate investment trust. Ares Capital is an enormous business development company with a 16-year history of steady-to-rising dividend payouts. 10 stocks we like better than Altria Group › Would your budget benefit from a significantly larger stream of passive income? There are many ways to make that happen, but I don't know of any that are easier than buying high-yield dividend stocks. Shares of Altria Group (NYSE: MO), Healthpeak Properties (NYSE: DOC), and Ares Capital (NASDAQ: ARCC) have been offering an average yield of 7.3% at recent prices. With such high yields, folks who invest $6,900 evenly among these three stocks could receive over $500 in annual dividend payments. Here's a closer look at each company to see how they could make excellent additions to an income-generating portfolio. 1. Altria Group Shares of the company that sells Marlboro brand cigarettes in the U.S. have risen about 15% over the past 12 months. Cigarette volumes are down, but investors have been encouraged by results for its smokeless-product offerings. Disposable vaporizers that deliver lots of nicotine for a fraction of the price of a pack of Marlboros have been a challenge. Marlboro shipment volume dropped by 11.4% year over year in the second quarter. The company lost a lot of market share to disposable e-vapor products that evade the regulatory process. Despite that, second-quarter revenue -- net of excise taxes -- declined by just 0.4% year over year. Top-line sales have been declining slowly, but margin expansion has allowed Altria Group's bottom line to grow. Second-quarter operating income climbed by 4.4% year over year. Altria stock has been rising because it looks like the company's other nicotine-delivery products can offset Marlboro losses. Oral tobacco product sales rose by 6% year over year, net of excise taxes. The company could also see a tailwind from increasing oversight of unauthorized nicotine products. Over the past 90 days, the Food and Drug Administration (FDA) has issued 58 warning letters to importers and retailers who sell Geek Bar and similar unauthorized e-vapor products. Altria Group shares offer a 6.7% yield at recent prices, and another dividend raise is probably around the corner. The company raised its dividend payout last August, which was the 59th payout raise announced in 55 years. 2. Healthpeak Properties If there's one thing you can count on, it's rising healthcare needs. Healthpeak Properties is a real estate investment trust (REIT) focused on outpatient medical buildings, laboratories used by drug developers, and retirement communities. Buying shares of this company is an easy way for income-seeking investors to follow the unstoppable healthcare trend. Shares of Healthpeak offer a 6.9% dividend yield at recent prices. Following the COVID-19 pandemic, institutional investors' enthusiasm for biotechnology start-ups fell off a cliff. Healthpeak rents labs to established pharmaceutical companies, start-up biotechs, and everything in between. Lack of demand for lab space from start-ups is a challenge this REIT fought by merging with Physician's Realty, an owner of medical office buildings, last year. Healthpeak acquired Physicians Realty in an all-stock transaction and had to reduce its dividend payment due to the creation of new shares. Investors can reasonably expect significant dividend payout raises in the years ahead. In the second quarter, adjusted funds from operations (FFO), a proxy for earnings used to evaluate REITs, rose to $0.44 per share. This is more than enough to keep up with monthly dividend payments, which are currently set at $0.305 per share per quarter. 3. Ares Capital Ares Capital is a business development company (BDC). These special entities exist to fill the hole left by traditional banks, which hardly ever give direct loans to businesses anymore. Starved for capital, businesses with millions in annual revenue are eager to borrow at interest rates that you might find surprising. During the third quarter, the BDC reported a 10.9% average yield on the debt securities in its portfolio. Shares of Ares Capital offer an 8.4% yield at recent prices. One-time, extra dividend payments in past years make the stock look more unpredictable than it is. Investors seeking a reliable income stream will be glad to know this company's quarterly payout has risen or remained stable since 2009. Lending directly to midsize businesses isn't the easiest banking operation, but Ares Capital has more resources than most of its peers. It's externally managed by a subsidiary of Ares Management, a leader in the alternative investment space, with about $546 billion in assets under management. Ares Capital can boast a highly experienced team of underwriters. Just 1.2% of its loans were on non-accrual status at the end of June. Adding some shares to a diversified portfolio now looks like a great way to build up your passive-income stream. Should you invest $1,000 in Altria Group right now? Before you buy stock in Altria Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Altria Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $630,291!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,075,791!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025

IonQ Partners with Oak Ridge National Laboratory, Demonstrating Quantum Power Grid Optimization Advancements
IonQ Partners with Oak Ridge National Laboratory, Demonstrating Quantum Power Grid Optimization Advancements

Globe and Mail

time6 hours ago

  • Globe and Mail

IonQ Partners with Oak Ridge National Laboratory, Demonstrating Quantum Power Grid Optimization Advancements

IonQ (NYSE: IONQ), the leading commercial quantum computing and networking company, announced a new achievement in applying quantum technology to energy grid optimization challenges. Through a collaborative partnership between IonQ, Oak Ridge National Laboratory (ORNL), and the U.S. Department of Energy (DOE), the team has successfully demonstrated that its hybrid quantum-classical computing approach can address the Unit Commitment problem, a critical task for power grid operators. The Unit Commitment problem involves determining the optimal schedule for power generators to meet electricity demand at minimal cost. This task becomes increasingly complex as power systems scale and generate more energy using dispatchable energy resources (e.g. nuclear plants, natural gas, hydroelectric…etc.) and intermittent sources such as solar and wind. IonQ and ORNL developed a hybrid approach that combines IonQ's 36-qubit Forte Enterprise quantum computing with classical computing. Using this hybrid approach, the team found varied solutions for power generation scheduling across 24 time periods and 26 generators. 'This demonstration marks a significant milestone in applying quantum computing to real-world energy challenges. We are proud to be partnering on this ground-breaking work with ORNL and the DOE,' said Niccolo de Masi, CEO of IonQ. 'As our systems scale to thousands and millions of qubits, we expect to solve grid optimization challenges at a scale that classic computing methods cannot match.' The energy sector is increasingly viewed as a key early use case for quantum computing advantages, given its reliance on complex optimization and simulation tasks. According to the U.S. Energy Information Administration, more than 60% of energy used in electricity generation is currently lost, pointing to a significant opportunity for waste reduction through improved planning and computational methods. This research is part of DOE's multi-year GRID-Q project, which brings together national laboratories, academic partners, and private-sector companies. ORNL leads the project, with IonQ as one of only two quantum industry partners tasked with developing scalable quantum algorithms for grid operations. 'This case study, completed by ORNL in partnership with IonQ, demonstrated the feasibility of using an ion-trapped quantum computing device to solve the Unit Commitment problem in the power grid,' said Suman Debnath, who led ORNL's contributions to the project. 'As the quantum device scales, concurrent research is intended to test how the application performance can gain a quantum advantage.' IonQ anticipates that quantum systems with 100 to 200 high-fidelity qubits, which are expected as early as 2026, will be capable of solving grid-scale Unit Commitment problems. The quantum optimization methods demonstrated in this work are applicable to a broad range of industries, including logistics, scheduling, and finance. This latest announcement builds on the established relationship between IonQ and ORNL. The organizations have partnered on several projects including: noise-tolerant methods to help solve the world's hardest optimization problems as well as a novel approach to scalable quantum computing. IonQ is also engaged in a separate $22 million project with EPB of Chattanooga that includes optimizing the energy grid. About IonQ IonQ, Inc. [NYSE: IONQ] is the leading commercial quantum computing, quantum networking and quantum applications company , delivering high-performance systems aimed at solving the world's most complex problems. IonQ's current generation quantum computers, IonQ Forte and IonQ Forte Enterprise, are the latest in a line of cutting-edge systems that have been helping customers and partners such as Amazon Web Services, AstraZeneca, and NVIDIA achieve 20x performance results. The company is accelerating its technology roadmap and intends to deliver the world's most powerful quantum computers with 2 million qubits by 2030 to accelerate innovation in drug discovery, materials science, financial modeling, logistics, cybersecurity, and defense. IonQ's advancements in quantum networking also positions the company as a leader in building the quantum internet. The company's innovative technology and rapid growth were recognized in Newsweek's 2025 Excellence Index 1000, Forbes' 2025 Most Successful Mid-Cap Companies list, and Built In's 2025 100 Best Midsize Places to Work in Washington DC and Seattle, respectively. Available through all major cloud providers, IonQ is making quantum computing more accessible and impactful than ever before. Learn more at IonQ Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words 'anticipates,' 'can,' 'eventually,' 'expect,' 'expected,' 'ground-breaking,' 'opportunity,' 'scale,' 'will,' and other similar expressions are intended to identify forward-looking statements. These statements include those related to the IonQ's quantum computing capabilities and plans; IonQ's technology driving commercial quantum advantage or delivering scalable, fault-tolerant quantum computing in the future; the relevance and utility of quantum algorithms and applications run on IonQ's quantum computers; the necessity, effectiveness, and future impacts of IonQ's offerings available today; and the scalability, fidelity, efficiency, viability, accessibility, effectiveness, importance, reliability, performance, speed, impact, practicality, feasibility, and commercial-readiness of IonQ's offerings. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: IonQ's ability to implement its technical roadmap; changes in the competitive industries in which IonQ operates, including development of competing technologies; IonQ's ability to deliver, and customers' ability to generate, value from IonQ's offerings; IonQ's ability to implement its technical roadmaps, business plans, forecasts, and other expectations, to identify and realize partnerships and opportunities, and to engage new and existing customers; IonQ's ability to effectively enter new markets; IonQ's customers deciding or declining to extend contracts into new phases; changes in U.S. government spending or policy that may affect IonQ's customers; and risks associated with U.S. government sales, including availability of funding and provisions that may allow the government to unilaterally terminate or modify contracts for convenience; changes in laws and regulations affecting IonQ's patents; and IonQ's ability to maintain or obtain patent protection for its products and technology, including with sufficient breadth to provide a competitive advantage. You should carefully consider the foregoing factors and the other risks and uncertainties disclosed in the Company's filings, including but not limited to those described in the 'Risk Factors' section of IonQ's filings with the U.S. Securities and Exchange Commission, including but not limited to the Company's most recent Annual Report on Form 10-K and reports on Form 10-Q. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and IonQ assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. IonQ does not give any assurance that it will achieve its expectations.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store